查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1458033

全球类器官和球体市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Organoids And Spheroids Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

全球类器官和球体市场的需求预计将从 2023 年的 780.92 万美元达到 2032 年的近 5,444.06 万美元，在 2024 年至 2032 年的研究期间CAGR为 24.08%。

类器官和球体是三维细胞培养物，可模仿实验室环境中器官或组织的结构和功能。类器官是自组织的微型器官，而球体是具有球形形状的细胞聚集体。这些模型用于生物医学研究，以研究器官发育、疾病进展和药物测试。它们比传统细胞培养物更准确地表示体内条件，提供对复杂生物过程的见解并支持个人化医疗的进步。

市场动态

类器官和球体市场是由再生医学、药物发现和个人化医疗的进步以及利用三维 (3D) 细胞培养技术推动的。生物医学研究、药物筛选和疾病建模中对更多生理相关模型的需求促进了市场成长。这些 3D 细胞培养系统具有重现组织特异性功能、模拟复杂相互作用以及更接近反映体内条件的潜力，推动了它们在生命科学和製药行业的采用。此外，对减少对动物模型的依赖和对个人化治疗方法的需求的关注推动了类器官和球体的开发和利用。技术创新，包括生物製造技术以及先进成像和分析工具的集成，进一步支持类器官和球体在生物医学研究和治疗开发中的扩大应用。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球类器官和球体市场的每个细分市场进行了包容性评估。类器官和球体产业的成长和趋势为这项研究提供了整体方法。

市场区隔

类器官和球体市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。

按类型

  • 类器官（类型（神经类器官、肝类器官、肠类器官、其他类器官）、方法（类器官培养的一般浸没法、隐窝类器官培养技术、类器官培养的气液界面(Ali) 方法、来自Lgr5+ 细胞的克隆类器官、脑和视网膜类器官形成方案，其他），来源（原代组织，干细胞）
  • 球体（类型（多细胞肿瘤球体 (Mcts)、神经球、乳腺球、肝球、胚状体）、方法（微图案板、低细胞附着板、悬滴法、其他）、来源（细胞株、​​原代细胞、Ipscs 衍生细胞）

按申请

  • 发育生物学
  • 个人化医疗
  • 再生医学
  • 疾病病理学研究
  • 药毒及功效测试

按最终用途

  • 生物技术和製药业
  • 学术及研究机构
  • 医院和诊断中心

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲类器官和球体市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

  • 按地区分類的全球类器官和球体市场份额（代表性图）
  • 全球类器官和球体市场份额

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。类器官和球体市场的主要参与者包括 3D Biomatrix、3D Biotek LLC、AMS Biotechnology (Europe) Limited、Cellesce Ltd、康宁公司、Greiner Bio-One、Hubrecisht Organoid Technology (HUB)、InSphero、Lonza、Merck KGaA、Precisht Organoid Technology (HUB)、InSphero、Lonza、Merck KGaA、Precisht 有机体生物製剂、STEMCELL Technologies Inc.、Thermo Fisher Scientific, Inc.。本部分包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：类器官与球体 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球类器官和球体市场分析：按类型

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 类器官（类型（神经类器官、肝类器官、肠类器官、其他类器官）、方法（类器官培养的一般浸没法、隐窝类器官培养技术、类器官培养的气液界面(Ali) 方法、来自Lgr5+ 细胞的克隆类器官、脑和视网膜类器官形成方案，其他），来源（原代组织，干细胞）
  • 球体（类型（多细胞肿瘤球体 (Mcts)、神经球、乳腺球、肝球、胚状体）、方法（微图案板、低细胞附着板、悬滴法、其他）、来源（细胞株、​​原代细胞、Ipscs 衍生细胞）

第 6 章：全球类器官与球体市场分析：依应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 发育生物学
  • 个人化医疗
  • 再生医学
  • 疾病病理学研究
  • 药毒及功效测试

第 7 章：全球类器官与球体市场分析：依最终用途分类

  • 按最终用途分類的概述
  • 历史和预测数据
  • 按最终用途分析
  • 生物技术和製药业
  • 学术及研究机构
  • 医院和诊断中心

第 8 章：全球类器官与球体市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章：类器官与球体公司的竞争格局

  • 类器官和球体市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章：公司简介

  • 公司股份分析
  • 市场集中度
  • 3D Biomatrix
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • 3D Biotek LLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • AMS Biotechnology (Europe) Limited
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Cellesce Ltd
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Corning Incorporated
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Greiner Bio-One
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Hubrecht Organoid Technology (HUB)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • InSphero
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Lonza
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Merck KGaA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Prellis Biologics
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • STEMCELL Technologies Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Thermo Fisher Scientific Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR112113863

The global demand for Organoids And Spheroids Market is presumed to reach the market size of nearly USD 5444.06 MN by 2032 from USD 780.92 MN in 2023 with a CAGR of 24.08% under the study period 2024 - 2032.

Organoids and spheroids are three-dimensional cell cultures that mimic the structure & function of organs or tissues in a laboratory setting. Organoids are self-organized, miniature versions of organs, while spheroids are cell aggregates with spherical shapes. These models are used in biomedical research to study organ development, disease progression, and drug testing. They provide more accurate representations of in vivo conditions than traditional cell cultures, offering insights into complex biological processes and supporting advancements in personalized medicine.

MARKET DYNAMICS

The organoids and spheroids market is driven by advancements in regenerative medicine, drug discovery, and personalized medicine, leveraging three-dimensional (3D) cell culture technologies. The demand for more physiologically relevant models in biomedical research, drug screening, and disease modeling contributes market growth. The potential of these 3D cell culture systems to recapitulate tissue-specific functions, simulate complex interactions, and offer a closer representation of in vivo conditions fuels their adoption in the life sciences and pharmaceutical industries. Additionally, the focus on reducing reliance on animal models and the need for personalized treatment approaches drive the development and utilization of organoids and spheroids. Technological innovations, including biofabrication techniques and the integration of advanced imaging and analysis tools, further support the expanding applications of organoids and spheroids in biomedical research and therapeutic development.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of organoids and spheroids. The growth and trends of organoids and spheroids industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the organoids and spheroids market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Organoids (Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Other Organoids), Method (General Submerged Method For Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (Ali) Method For Organoid Culture, Clonal Organoids From Lgr5+ Cells, Brain And Retina Organoid Formation Protocol, Others), Source (Primary Tissues, Stem Cells)
  • Spheroids (Type (Multicellular Tumor Spheroids (Mcts), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies), Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Source (Cell Line, Primary Cell, Ipscs Derived Cells)

By Application

  • Developmental Biology
  • Personalized Medicine
  • Regenerative Medicine
  • Disease Pathology Studies
  • Drug Toxicity & Efficacy Testing

By End-Use

  • Biotechnology And Pharmaceutical Industries
  • Academic & Research Institutes
  • Hospitals And Diagnostic Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Organoids And Spheroids market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

  • GLOBAL ORGANOIDS AND SPHEROIDS MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
  • Global Organoids And Spheroids Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Organoids And Spheroids market include 3D Biomatrix, 3D Biotek LLC, AMS Biotechnology (Europe) Limited, Cellesce Ltd, Corning Incorporated, Greiner Bio-One, Hubrecht Organoid Technology (HUB), InSphero, Lonza, Merck KGaA, Prellis Biologics, STEMCELL Technologies Inc., Thermo Fisher Scientific, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ORGANOIDS AND SPHEROIDS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ORGANOIDS AND SPHEROIDS MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Organoids (Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Other Organoids), Method (General Submerged Method For Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (Ali) Method For Organoid Culture, Clonal Organoids From Lgr5+ Cells, Brain And Retina Organoid Formation Protocol, Others), Source (Primary Tissues, Stem Cells) Historic and Forecast Sales by Regions
  • 5.5 Spheroids (Type (Multicellular Tumor Spheroids (Mcts), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies), Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Source (Cell Line, Primary Cell, Ipscs Derived Cells) Historic and Forecast Sales by Regions

6 . GLOBAL ORGANOIDS AND SPHEROIDS MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Developmental Biology Historic and Forecast Sales by Regions
  • 6.5 Personalized Medicine Historic and Forecast Sales by Regions
  • 6.6 Regenerative Medicine Historic and Forecast Sales by Regions
  • 6.7 Disease Pathology Studies Historic and Forecast Sales by Regions
  • 6.8 Drug Toxicity & Efficacy Testing Historic and Forecast Sales by Regions

7 . GLOBAL ORGANOIDS AND SPHEROIDS MARKET ANALYSIS BY END-USE

  • 7.1 Overview by End-use
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-use
  • 7.4 Biotechnology and Pharmaceutical Industries Historic and Forecast Sales by Regions
  • 7.5 Academic & Research Institutes Historic and Forecast Sales by Regions
  • 7.6 Hospitals and Diagnostic Centers Historic and Forecast Sales by Regions

8 . GLOBAL ORGANOIDS AND SPHEROIDS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ORGANOIDS AND SPHEROIDS COMPANIES

  • 9.1. Organoids And Spheroids Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF ORGANOIDS AND SPHEROIDS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. 3D Biomatrix
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. 3D Biotek LLC
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. AMS Biotechnology (Europe) Limited
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Cellesce Ltd
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Corning Incorporated
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Greiner Bio-One
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Hubrecht Organoid Technology (HUB)
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. InSphero
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Lonza
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Merck KGaA
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. Prellis Biologics
    • 10.13.1. Company Overview
    • 10.13.2. Company Revenue
    • 10.13.3. Products
    • 10.13.4. Recent Developments
  • 10.14. STEMCELL Technologies Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Company Revenue
    • 10.14.3. Products
    • 10.14.4. Recent Developments
  • 10.15. Thermo Fisher Scientific Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Company Revenue
    • 10.15.3. Products
    • 10.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Organoids (Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Other Organoids), Method (General Submerged Method For Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (Ali) Method For Organoid Culture, Clonal Organoids From Lgr5+ Cells, Brain And Retina Organoid Formation Protocol, Others), Source (Primary Tissues, Stem Cells) Market Sales by Geography (USD MN)
  • Spheroids (Type (Multicellular Tumor Spheroids (Mcts), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies), Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Source (Cell Line, Primary Cell, Ipscs Derived Cells) Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Developmental Biology Market Sales by Geography (USD MN)
  • Personalized Medicine Market Sales by Geography (USD MN)
  • Regenerative Medicine Market Sales by Geography (USD MN)
  • Disease Pathology Studies Market Sales by Geography (USD MN)
  • Drug Toxicity & Efficacy Testing Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Biotechnology and Pharmaceutical Industries Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Hospitals and Diagnostic Centers Market Sales by Geography (USD MN)
  • Global Organoids And Spheroids Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Organoids And Spheroids Report
  • Market Research Process
  • Market Research Methodology
  • Global Organoids And Spheroids Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Organoids (Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Other Organoids), Method (General Submerged Method For Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (Ali) Method For Organoid Culture, Clonal Organoids From Lgr5+ Cells, Brain And Retina Organoid Formation Protocol, Others), Source (Primary Tissues, Stem Cells) Market Sales by Geography (USD MN)
  • Spheroids (Type (Multicellular Tumor Spheroids (Mcts), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies), Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Source (Cell Line, Primary Cell, Ipscs Derived Cells) Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Developmental Biology Market Sales by Geography (USD MN)
  • Personalized Medicine Market Sales by Geography (USD MN)
  • Regenerative Medicine Market Sales by Geography (USD MN)
  • Disease Pathology Studies Market Sales by Geography (USD MN)
  • Drug Toxicity & Efficacy Testing Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Biotechnology and Pharmaceutical Industries Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Hospitals and Diagnostic Centers Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.